2010

Fuentes-Calvo I, Blázquez-Medela AM, Santos E, López-Novoa JM, Martínez-Salgado C. Analysis of K-ras nuclear expression in fibroblasts and mesangial cells. PLoS One 5(1): e8703, 2010.

Blázquez-Medela AM, López-Novoa JM, Martínez-Salgado C. Mechanisms involved in the genesis of diabetic nephropathy. Current Diabetes Reviews 6 (2): 68-87, 2010

Grande MT, Fuentes-Calvo I, Arévalo M, Heredia F, Santos E, Martínez-Salgado C, Rodríguez-Puyol D, Nieto MA, López-Novoa JM. Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice. Kidney International 77 (6): 509-518, 2010.

Gómez-Marcos MA, Martínez-Salgado C, Grandes G, Recio-Rodriguez JI, Castaño Sánchez Y, Rodríguez-Sánchez E, García-Ortiz L. Lesión orgánica subclínica y nefropatía en hipertensos de nuevo diagnóstico. Medicina Clínica 134 (6): 246-253, 2010.

López-Novoa JM, Martínez-Salgado C, Rodríguez-Peña AB, López Hernández FJ. Common pathophysiological mechanisms of chronic kidney diseases: therapeutic perspectivas. Pharmacology & Therapeutics 128 (1): 61-81, 2010.

Blázquez-Medela AM, García-Ortiz L, Gómez-Marcos MA, Recio-Rodríguez JI, Sánchez-Rodríguez A, López-Novoa JM, Martínez-Salgado C. Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients. BMC Medicine 8: 86, 2010

Eleno N, Düwel A, Muñoz A, Paz-Bouza J, López-Novoa JM, Lozano F. Endoglin as a marker in cervical paragangliomas. Head and Neck 32: 737-743, 2010

Eleno N, Lozano F, Lopez-Novoa JM. Endoglin as a marker in paragangliomas: a reply to Letter to the Editor HED-10-0272. Head and Neck 32(7): 971, 2010

Quiros Y, Ferreira L, Sancho-Martínez SM, González-Buitrago JM, López-Novoa JM, López-Hernández FJ. Sub-nephrotoxic doses of gentamicin predispose animals to developing acute kidney injury and to excrete ganglioside M2 activator protein. Kidney Int. 78: 1006-1015, 2010.

Núñez R, Sancho-Martínez SM, Novoa JM, López-Hernández FJ. Apoptotic volume decrease as a geometric determinant for cell dismantling into apoptotic bodies. Cell Death Differ. 17: 1665-1671, 2010.

Vicente-Vicente L, Quiros Y, Pérez-Barriocanal F, López-Novoa JM, López-Hernández FJ, Morales AI. Nephrotoxicity of uranium: pathophysiological, diagnostic and therapeutic perspectives. Toxicol Sci. 118: 324-347, 2010.

García-Sánchez O, López-Hernández FJ, López-Novoa JM. An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease. Kidney Int. 77: 950-955, 2010.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s